Byooviz Injection, Solution
Product Images NDC 82667-018

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Byooviz (NDC 82667-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Sb11 01)

Figure (Sb11 01)
FDA Label Image

Figure (Sb11 02)

Figure (Sb11 02)
FDA Label Image

Figure (Sb11 03)

Figure (Sb11 03)
FDA Label Image

Figure (Sb11 04)

Figure (Sb11 04)
FDA Label Image

Figure (Sb11 05)

Figure (Sb11 05)
FDA Label Image

Figure 1 (Sb11 06)

Figure 1 (Sb11 06)
This is an evaluation of the mean change in visual acuity (letters) over a span of 24 months for a condition referred to as AMD-2. The data shows a fluctuation in visual acuity scores over the timeline provided.*
FDA Label Image

Figure (Sb11 07)

Figure (Sb11 07)
FDA Label Image

Figure (Sb11 08)

Figure (Sb11 08)
FDA Label Image

Figure (Sb11 09)

Figure (Sb11 09)
FDA Label Image

Figure (Sb11 10)

Figure (Sb11 10)
FDA Label Image

Figure 2 (Sb11 11)

Figure 2 (Sb11 11)
FDA Label Image

Figure (Sb11 12)

Figure (Sb11 12)
FDA Label Image

Figure (Sb11 13)

Figure (Sb11 13)
FDA Label Image

Figure 3 (Sb11 14)

Figure 3 (Sb11 14)
FDA Label Image

Figure (Sb11 15)

Figure (Sb11 15)
FDA Label Image

Figure (Sb11 16)

Figure (Sb11 16)
FDA Label Image

Figure 4 (Sb11 17)

Figure 4 (Sb11 17)
This text shows a graph with the percentage of patients receiving a certain number of injections. The mean number of injections is 10.3. The x-axis represents the number of injections, and the y-axis represents the percentage of patients.*
FDA Label Image

Figure 5 (Sb11 18)

Figure 5 (Sb11 18)
FDA Label Image

Figure (Sb11 19)

Figure (Sb11 19)
FDA Label Image

Figure (Sb11 20)

Figure (Sb11 20)
FDA Label Image

Figure (Sb11 21)

Figure (Sb11 21)
FDA Label Image

Figure (Sb11 22)

Figure (Sb11 22)
FDA Label Image

Figure 6 (Sb11 23)

Figure 6 (Sb11 23)
FDA Label Image

Principal Display Panel (0.5 mg Vial Carton)

Principal Display Panel (0.5 mg Vial Carton)
This text contains information regarding a medication called Byooviz, which is an injection containing ranibizumab-nuna. It is supplied in a 0.5 ml single-dose vial that should be kept refrigerated and protected from light. The medication is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mcNV). The storage instructions, dosage information, and details about the manufacturer are also provided in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.